Low-density lipoprotein decorated and indocyanine green loaded silica nanoparticles for tumor-targeted photothermal therapy of breast cancer

References

• Ao M, Xiao X, Ao Y. 2018. Low density lipoprotein modified silica nanoparticles loaded with docetaxel and thalidomide for effective chemotherapy of liver cancer. Braz J Med Biol Res. 51:1–10.
   PubMed Web of Science ®Google Scholar
• Cao Y, Song J, Ge J, Song Z, Chen J, Wu C. 2018. MicroRNA-100 suppresses human gastric cancer cell proliferation by targeting CXCR7. Oncol Lett. 15:453–458.
   PubMed Web of Science ®Google Scholar
• Chai S, Kan S, Sun R, Zhou R, Sun Y, Chen W, Yu B. 2018. Fabricating polydopamine-coated MoSe2-wrapped hollow mesoporous silica nanoplatform for controlled drug release and chemo-photothermal therapy. Int J Nanomedicine. 13:7607–7621.
   PubMed Web of Science ®Google Scholar
• Chen Q, Xu L, Liang C, Wang C, Peng R, Liu Z. 2016. Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy. Nat Commun. 7:13193.
   PubMed Web of Science ®Google Scholar
• Chen L, He W, Jiang H, Wu L, Xiong W, Li B, Zhou Z, Qian Y. 2018. In vivo SELEX of bone targeting aptamer in prostate cancer bone metastasis model. Int J Nanomedicine. 14:149–159.
   PubMed Web of Science ®Google Scholar
• Chen WL, Yang SD, Li F, Qu CX, Liu Y, Wang Y, Wang DD, Zhang XN. 2018. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo. Acta Biomater. 81:219–230.
   PubMed Web of Science ®Google Scholar
• Cong VT, Ly NH, Son SJ, Min J, Joo SW. 2017. Silica-encapsulated gold nanoparticle dimers for organelle-targeted cellular delivery. Chem Commun. 53:5009–5012.
   PubMed Web of Science ®Google Scholar
• Ding X, Xu X, Zhao Y, Zhang L, Yu Y, Huang F, Yin D, Huang H. 2017. Tumor targeted nanostructured lipid carrier co-delivering paclitaxel and indocyanine green for laser triggered synergetic therapy of cancer. RSC Adv. 7:35086–35095.
   Web of Science ®Google Scholar
• Fang J, Zhang S, Xue X, Zhu X, Song S, Wang B, Jiang L, Qin M, Liang H, Gao L, et al. 2018. Quercetin and doxorubicin co-delivery using mesoporous silica nanoparticles enhance the efficacy of gastric carcinoma chemotherapy. Int J Nanomedicine. 13:5113–5126.
   PubMed Web of Science ®Google Scholar
• Fang RH, Hu CMJ, Luk BT, Gao W, Copp JA, Tai Y, O’Connor DE, Zhang L. 2014. Cancer cell membrane-coated nanoparticles for anticancervaccination and drug delivery. Nano Lett. 14:2181–2188.
   PubMed Web of Science ®Google Scholar
• Furuya Y, Sekine Y, Kato H, Miyazawa Y, Koike H, Suzuki K. 2016. Low-density lipoprotein receptors play an important role in the inhibition of prostate cancer cell proliferation by statins. Prostate Int. 4:56.
   PubMed Web of Science ®Google Scholar
• Gu L, Shi T, Sun Y, You C, Wang S, Wen G, Chen L, Zhang X, Zhu J, Sun B, et al. 2017. Folate-modified, indocyanine green-loaded lipid-polymer hybrid nanoparticles for targeted delivery of cisplatin. J Biomater Sci Polym Ed. 28:690–702.
   PubMed Web of Science ®Google Scholar
• Hu CMJ, Zhang L, Aryal S, Cheung C, Fang RH, Zhang L. 2011. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci USA. 108:10980–10985.
   PubMed Web of Science ®Google Scholar
• Kovanen PT, Bilheimer DW, Goldstein JL, Jaramillo JJ, Brown MS. 1981. Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog. Proc Natl Acad Sci USA. 78:1194–1198.
   PubMed Web of Science ®Google Scholar
• Lu Q, Yi M, Zhang M, Shi Z, Zhang S. 2019. Folate-conjugated cell membrane mimetic polymer micelles for tumor cell-targeted delivery of doxorubicin. Langmuir. 35:504–512.
   PubMed Web of Science ®Google Scholar
• Martinez-Carmona M, Lozano D, Colilla M, Vallet-Regi M. 2018. Lectin-conjugated pH-responsive mesoporous silica nanoparticles for targeted bone cancer treatment. Acta Biomater. 65:393–404.
   PubMed Web of Science ®Google Scholar
• Meng LX, Ren Q, Meng Q, Zheng YX, He ML, Sun SY, Ding ZJ, Li BC, Wang HY. 2018. Trastuzumab modified silica nanoparticles loaded with doxorubicin for targeted and synergic therapy of breast cancer. Artif Cells Nanomed Biotechnol. 46:S556–S563.
   PubMed Web of Science ®Google Scholar
• Nikanjam M, Blakely EA, Bjornstad KA, Shu X, Budinger TF, Forte TM. 2007. Synthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiforme. Int J Pharm. 328:86–94.
   PubMed Web of Science ®Google Scholar
• Rudling MJ, Ståhle L, Peterson CO, Skoog L. 1986. Content of low density lipoprotein receptors in breast cancer tissue related to survival of patients. Br Med J. 292:580–582.
   PubMed Web of Science ®Google Scholar
• Saxena V, Sadoqi M, Shao J. 2004. Enhanced photo-stability, thermal-stability and aqueous-stability of indocyanine green in polymeric nanoparticulate systems. J Photochem Photobiol B Biol. 74:29–38.
   PubMed Web of Science ®Google Scholar
• Sheng Y, Chang L, Kuang T, Hu J. 2016. PEG/heparin-decorated lipid–polymer hybrid nanoparticles for long-circulating drug delivery. Rsc Adv. 6:23279–23287.
   Web of Science ®Google Scholar
• Stopeck AT, Nicholson AC, Mancini FP, Hajjar DP. 1993. Cytokine regulation of low density lipoprotein receptor gene transcription in HepG2 cells. J Biol Chem. 268:17489–17494.
   PubMed Web of Science ®Google Scholar
• Tambe P, Kumar P, Paknikar KM, Gajbhiye V. 2018. Decapeptide functionalized targeted mesoporous silica nanoparticles with doxorubicin exhibit enhanced apoptotic effect in breast and prostate cancer cells. Int J Nanomedicine. 13:7669–7680.
   PubMed Web of Science ®Google Scholar
• Tang D, Zhao X, Yang T, Wang C. 2018. Paclitaxel prodrug based mixed micelles for tumor-targeted chemotherapy. RSC Adv. 8:380–389.
   Web of Science ®Google Scholar
• Tang D, Zhao X, Zhang L, Wang Z, Wang C. 2019. Identification of hub genes to regulate breast cancer metastasis to brain by bioinformatics analyses. J Cell Biochem. 120:9522–9531.
   PubMed Web of Science ®Google Scholar
• Uppal S, Italiya KS, Chitkara D, Mittal A. 2018. Nanoparticulate-based drug delivery systems for small molecule anti-diabetic drugs: an emerging paradigm for effective therapy. Acta Biomater. 81:20–42.
   PubMed Web of Science ®Google Scholar
• Wang C, Chen S, Yu Q, Hu F, Yuan H. 2017. Taking advantage of the disadvantage: employing the high aqueous instability of amorphous calcium carbonate to realize burst drug release within cancer cells. J Mater Chem B. 5:2068–2073.
   PubMed Web of Science ®Google Scholar
• Wang C, Han M, Liu X, Chen S, Hu F, Sun J, Yuan H. 2019. Mitoxantrone-preloaded water-responsive phospholipid-amorphous calcium carbonate hybrid nanoparticles for targeted and effective cancer therapy. Int J Nanomedicine. 14:1503–1517.
   PubMed Web of Science ®Google Scholar
• Wang C, Liu X, Chen S, Hu F, Sun J, Yuan H. 2018. Facile preparation of phospholipid–amorphous calcium carbonate hybrid nanoparticles: toward controllable burst drug release and enhanced tumor penetration. Chem Commun. 54:13080–13083.
   PubMed Web of Science ®Google Scholar
• Wang C, Wang Z, Zhao X, Yu F, Quan Y, Cheng Y, Yuan H. 2019. DOX loaded aggregation-induced emission active polymeric nanoparticles as a fluorescence resonance energy transfer traceable drug delivery system for self-indicating cancer therapy. Acta Biomater. 85:218–228.
   PubMed Web of Science ®Google Scholar
• Wang C, Yu F, Liu X, Chen S, Wu R, Zhao R, Hu F, Yuan H. 2019. Cancer-specific therapy by artificial modulation of intracellular calcium concentration. Adv Healthcare Mater. 8:1900501.
   Web of Science ®Google Scholar
• Wang JY, Mu X, Li Y, Xu F, Long W, Yang J, Bian P, Chen J, Ouyang L, Liu H. 2018. Hollow PtPdRh nanocubes with enhanced catalytic activities for in vivo clearance of radiation‐induced ROS via surface‐mediated bond breaking. Small. 14:1703736.
   Web of Science ®Google Scholar
• Wang S, Liu F, Li XL. 2017. Monitoring of “on-demand” drug release using dual tumor marker mediated DNA-capped versatile mesoporous silica nanoparticles. Chem Commun. 53:8755–8758.
   PubMed Web of Science ®Google Scholar
• Wu L, Ni C, Zhang L, Shi G, Bai X, Zhou Y, He F. 2016. Surface charge convertible and biodegradable synthetic zwitterionic nanoparticles for enhancing cellular drug uptake. Macromol Biosci. 16:308–313.
   PubMed Web of Science ®Google Scholar
• Xiang SD, Wilson KL, Goubier A, Heyerick A, Plebanski M. 2018. Design of peptide-based nanovaccines targeting leading antigens from gynecological cancers to induce HLA-A2.1 restricted CD8(+) T cell responses. Front Immunol. 9:2968.
   PubMed Web of Science ®Google Scholar
• Xiong H, Du S, Zhang P, Jiang Z, Zhou J, Yao J. 2018. Primary tumor and pre-metastatic niches co-targeting “peptides-lego” hybrid hydroxyapatite nanoparticles for metastatic breast cancer treatment. Biomater Sci. 6:2591–2604.
   PubMed Web of Science ®Google Scholar
• Xiong H, Ni J, Jiang Z, Tian F, Zhou J, Yao J. 2018. Intracellular self-disassemble polysaccharide nanoassembly for multi-factors tumor drug resistance modulation of doxorubicin. Biomater Sci. 6:2527–2540.
   PubMed Web of Science ®Google Scholar
• Xiong H, Wu Y, Jiang Z, Zhou J, Yang M, Yao J. 2019. pH-activatable polymeric nanodrugs enhanced tumor chemo/antiangiogenic combination therapy through improving targeting drug release. J Colloid Interface Sci. 536:135–148.
   PubMed Web of Science ®Google Scholar
• Yang RM, Fu C, Fang J, Xu X, Wei X, Tang W, Jiang X, Zhang L. 2016. Hyaluronan-modified superparamagnetic iron oxide nanoparticles for bimodal breast cancer imaging and photothermal therapy. Int J Nanomedicine. 12:197–206.
   PubMed Web of Science ®Google Scholar
• Ye J, Zhang R, Chai W, Du X. 2018. Low-density lipoprotein decorated silica nanoparticles co-delivering sorafenib and doxorubicin for effective treatment of hepatocellular carcinoma. Drug Deliv. 25:2007–2014.
   PubMed Web of Science ®Google Scholar
• Zhang L, Qin D, Hao C, Shu X, Pei D. 2013. SNX16 negatively regulates the migration and tumorigenesis of MCF-7 cells. Cell Regen. 2:2:3.
   Google Scholar
• Zhang N, Tao J, Hua H, Sun P, Zhao Y. 2015. Low-density lipoprotein peptide-combined DNA nanocomplex as an efficient anticancer drug delivery vehicle. Eur J Pharm Biopharm. 94:20.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu L, Lin L, Chen J, Tian H, Chen X, Maruyama A. 2018. In situ dual-crosslinked nanoparticles for tumor targeting gene delivery. Acta Biomater. 65:349–362.
   PubMed Web of Science ®Google Scholar
• Zhao X, Tang D, Yang T, Wang C. 2018. Facile preparation of biocompatible nanostructured lipid carrier with ultra-small size as a tumor-penetration delivery system. Colloids Surf B Biointerfaces. 170:355–363.
   PubMed Web of Science ®Google Scholar
• Zhao X, Tang DY, Zuo X, Zhang TD, Wang C. 2019. Identification of lncRNA–miRNA–mRNA regulatory network associated with epithelial ovarian cancer cisplatin-resistant. J Cell Physiol. 234:19886–19894.
   PubMed Web of Science ®Google Scholar
• Zheng T, Li GG, Zhou F, Wu R, Zhu JJ, Wang H. 2016. Gold-nanosponge-based multistimuli-responsive drug vehicles for targeted chemo-photothermal therapy. Adv Mater. 28:8218–8226.
   PubMed Web of Science ®Google Scholar